drugset / Trial / NCT02642523
Natriuretic Peptides and Metabolic Risk in Obesity
Non-randomizedCrossoverOpen-labelOther
Summary
The investigators are examining: 1. the relationships of insulin levels and natriuretic peptide hormone levels, and 2. the effects of administering an infusion of natriuretic peptide hormone on the breakdown of fat in healthy lean and otherwise healthy obese individuals.
Timeline
- Start
- —
- Primary completion
- 2017-02
- Completion
- 2017-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Insulin | Protein / enzyme biologic | — | Intravenous |
| Subject | Nesiritide | Protein / enzyme biologic | 0.01 ug/kg | Intravenous |